Thursday, 23 December 2010

Ulesfia


Ulesfia is a brand name of benzyl alcohol topical, approved by the FDA in the following formulation(s):


ULESFIA (benzyl alcohol - lotion; topical)



  • Manufacturer: SHIONOGI INC

    Approval date: April 9, 2009

    Strength(s): 5% [RLD]

Has a generic version of Ulesfia been approved?


No. There is currently no therapeutically equivalent version of Ulesfia available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ulesfia. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Methods and compositions for topical treatment of ectoparasites
    Patent 5,858,383
    Issued: January 12, 1999
    Inventor(s): Precopio; Michael J.
    Assignee(s): Summers Laboratories, Inc.
    Methods and compositions for the topical treatment of ectoparasites on animal skin utilizing a water-soluble or water-dispersible, substantially air-impermeable liquid composition.
    Patent expiration dates:

    • August 11, 2017
      ✓ 
      Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS




  • Methods and compositions for topical treatment of ectoparasites
    Patent 6,139,859
    Issued: October 31, 2000
    Inventor(s): Precopio; Michael J
    Assignee(s): Summers Laboratories, Inc.
    Methods and compositions for the topical treatment of ectoparasites on animal skin utilizing a water-soluble or water-dispersible, substantially air-impermeable liquid composition.
    Patent expiration dates:

    • August 11, 2017
      ✓ 
      Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS




  • Ectoparasite asphyxiator compositions and methods for their applications
    Patent 6,793,931
    Issued: September 21, 2004
    Inventor(s): Michael J; Precopio
    Assignee(s): Summers Laboratories, Inc.
    Water-soluble or water-dispersible, substantially air-impermeable, pharmacologically acceptable, liquid barrier compositions for treating ectoparasite infestations on animal skin and hair, wherein the compositions contain at least one monohydric aralkyl alcohol to prevent the ectoparasites from closing their respiratory systems.
    Patent expiration dates:

    • July 11, 2022
      ✓ 
      Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS
      ✓ 
      Drug product




  • Ectoparasite asphyxiator compositions and methods for their application
    Patent 7,294,342
    Issued: November 13, 2007
    Inventor(s): Precopio; Michael J
    Assignee(s): Summers Laboratories, Inc.
    Water-soluble or water-dispersible, substantially air-impermeable, pharmacologically acceptable, liquid barrier compositions for treating ectoparasite infestations on animal skin and hair, wherein the compositions contain at least one monohydric aralkyl alcohol to prevent the ectoparasites from closing their respiratory systems, and wherein the compositions are free from pesticides.
    Patent expiration dates:

    • May 19, 2024
      ✓ 
      Patent use: TOPICAL TREATMENT OF LICE INFESTATIONS



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • April 9, 2014 - NEW CHEMICAL ENTITY

See also...

  • Ulesfia Consumer Information (Drugs.com)
  • Ulesfia Lotion Consumer Information (Wolters Kluwer)
  • Benzyl Alcohol Consumer Information (Drugs.com)
  • Benzyl Alcohol Lotion Consumer Information (Wolters Kluwer)

Sunday, 19 December 2010

Vista-Methasone




Vista-Methasone may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vista-Methasone



Betamethasone

Betamethasone 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Vista-Methasone in the following countries:


  • United Kingdom

International Drug Name Search

Friday, 17 December 2010

Piperacillin / Tazobactam Stragen




Piperacillin/Tazobactam Stragen may be available in the countries listed below.


Ingredient matches for Piperacillin/Tazobactam Stragen



Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Piperacillin/Tazobactam Stragen in the following countries:


  • Germany

  • Sweden

Tazobactam

Tazobactam sodium salt (a derivative of Tazobactam) is reported as an ingredient of Piperacillin/Tazobactam Stragen in the following countries:


  • Germany

  • Sweden

International Drug Name Search

Friday, 10 December 2010

Solu Tracin




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Solu Tracin



Bacitracin

Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of Solu Tracin in the following countries:


  • United States

International Drug Name Search

Wednesday, 8 December 2010

Rotarix


Generic Name: rotavirus vaccine, live (Oral route)


ROE-ta-vye-rus VAX-een, lyve


Commonly used brand name(s)

In the U.S.


  • Rotarix

  • RotaTeq

Available Dosage Forms:


  • Powder for Suspension

  • Suspension

Therapeutic Class: Vaccine


Uses For Rotarix


Rotavirus vaccine live is used to prevent infants and children from getting a rotavirus stomach infection. It works by causing your body to produce its own protection (antibodies) against the virus.


Rotavirus is a serious infection that causes diarrhea and vomiting. It may also cause severe dehydration in infants and children.


This vaccine is to be administered only by or under the supervision of your child's doctor.


Before Using Rotarix


In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of live rotavirus vaccine in infants younger than 6 weeks of age or older than 24 weeks of age. Safety and efficacy have not been established.


Geriatric


No information is available on the relationship of age to the effects of live rotavirus vaccine in geriatric patients.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this vaccine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Receiving this vaccine with any of the following medicines is not recommended. Your doctor may decide not to use this vaccine or change some of the other medicines you take.


  • Aclarubicin

  • Aldesleukin

  • Altretamine

  • Amonafide

  • Amsacrine

  • Asparaginase

  • Azacitidine

  • Betamethasone

  • Bleomycin

  • Broxuridine

  • Busulfan

  • Capecitabine

  • Carboplatin

  • Carmustine

  • Chlorambucil

  • Cisplatin

  • Cladribine

  • Corticotropin

  • Cortisone

  • Cosyntropin

  • Cyclophosphamide

  • Cytarabine

  • Cytarabine Liposome

  • Dacarbazine

  • Dactinomycin

  • Daunorubicin

  • Daunorubicin Citrate Liposome

  • Decitabine

  • Deflazacort

  • Dexamethasone

  • Docetaxel

  • Doxifluridine

  • Doxorubicin Hydrochloride

  • Doxorubicin Hydrochloride Liposome

  • Edatrexate

  • Eflornithine

  • Epirubicin

  • Estramustine

  • Etoposide

  • Floxuridine

  • Fludarabine

  • Fludrocortisone

  • Fluocortolone

  • Fluorouracil

  • Fotemustine

  • Gallium Nitrate

  • Gemcitabine

  • Hydrocortisone

  • Hydroxyurea

  • Idarubicin

  • Ifosfamide

  • Interferon Alfa

  • Interferon Alfacon-1

  • Interferon Beta

  • Interferon Beta-1a

  • Interferon Beta-1b

  • Interferon Gamma

  • Irinotecan

  • Lomustine

  • Mechlorethamine

  • Melphalan

  • Mercaptopurine

  • Methotrexate

  • Methylprednisolone

  • Mitolactol

  • Mitomycin

  • Mitotane

  • Mitoxantrone

  • Oxaliplatin

  • Paclitaxel

  • Paclitaxel Protein-Bound

  • Paramethasone

  • Pegaspargase

  • Pentostatin

  • Pipobroman

  • Pirarubicin

  • Plicamycin

  • Prednisolone

  • Prednisone

  • Procarbazine

  • Raltitrexed

  • Rituximab

  • Streptozocin

  • Teceleukin

  • Tegafur

  • Teniposide

  • Thioguanine

  • Thiotepa

  • Topotecan

  • Treosulfan

  • Triamcinolone

  • Trimetrexate

  • Trofosfamide

  • Uracil Mustard

  • Vinblastine

  • Vincristine

  • Vincristine Liposome

  • Vindesine

  • Vinorelbine

Receiving this vaccine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Aclarubicin

  • Adalimumab

  • Aldesleukin

  • Alemtuzumab

  • Altretamine

  • Amonafide

  • Amsacrine

  • Asparaginase

  • Azacitidine

  • Azathioprine

  • Bleomycin

  • Broxuridine

  • Busulfan

  • Capecitabine

  • Carboplatin

  • Carmustine

  • Certolizumab Pegol

  • Chlorambucil

  • Cisplatin

  • Cladribine

  • Cyclophosphamide

  • Cytarabine

  • Cytarabine Liposome

  • Dacarbazine

  • Dactinomycin

  • Daunorubicin

  • Daunorubicin Citrate Liposome

  • Decitabine

  • Docetaxel

  • Doxifluridine

  • Doxorubicin Hydrochloride

  • Doxorubicin Hydrochloride Liposome

  • Edatrexate

  • Eflornithine

  • Epirubicin

  • Estramustine

  • Etanercept

  • Etoposide

  • Everolimus

  • Fingolimod

  • Floxuridine

  • Fludarabine

  • Fluorouracil

  • Fotemustine

  • Gallium Nitrate

  • Gemcitabine

  • Golimumab

  • Hydroxyurea

  • Idarubicin

  • Ifosfamide

  • Irinotecan

  • Lomustine

  • Mechlorethamine

  • Melphalan

  • Mercaptopurine

  • Methotrexate

  • Mitolactol

  • Mitomycin

  • Mitotane

  • Mitoxantrone

  • Mycophenolic Acid

  • Oxaliplatin

  • Paclitaxel

  • Pegaspargase

  • Pentostatin

  • Pipobroman

  • Pirarubicin

  • Plicamycin

  • Procarbazine

  • Raltitrexed

  • Rilonacept

  • Rituximab

  • Sirolimus

  • Streptozocin

  • Tacrolimus

  • Teceleukin

  • Tegafur

  • Temsirolimus

  • Teniposide

  • Thioguanine

  • Thiotepa

  • Topotecan

  • Treosulfan

  • Trimetrexate

  • Trofosfamide

  • Uracil Mustard

  • Ustekinumab

  • Vinblastine

  • Vincristine

  • Vincristine Liposome

  • Vindesine

  • Vinorelbine

Receiving this vaccine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abatacept

  • Leflunomide

  • Vaccinia Immune Globulin, Human

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Cancer or

  • Weak immune system (e.g., from HIV or AIDS or medicines)—These conditions may increase the risk for serious side effects.

  • Diarrhea or

  • Vomiting—Use with caution. May make these conditions worse.

  • Blocked or slow bowels, history of or

  • Intussusception (serious bowel problem), history of or

  • Meckel's diverticulum (a bowel disease), history of or

  • Severe combined immunodeficiency disease (SCID) (an inherited disease)—Should not be used in patients with these conditions.

Proper Use of rotavirus vaccine, live

This section provides information on the proper use of a number of products that contain rotavirus vaccine, live. It may not be specific to Rotarix. Please read with care.


A nurse or other trained health professional will give your child this vaccine. It is given by mouth.


This medicine needs to be given on a fixed schedule. If your child missed the scheduled dose, call your child’s doctor for another appointment.


This medicine comes with a patient information leaflet. Read the information carefully. Ask your doctor if you have any questions.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (suspension):
    • To prevent rotavirus infection:
      • Infants and children older than 24 weeks of age—Use and dose must be determined by your doctor.

      • Infants 6 to 24 weeks of age—The first dose should be given at around 6 weeks of age. The second dose should be given at least 4 weeks after the first dose. Both doses must be completed before the baby is 24 weeks of age (6 months).

      • Infants younger than 6 weeks of age—Use and dose must be determined by your doctor.



Precautions While Using Rotarix


It is very important that your child's doctor check your child's progress at regular visits to make sure that this vaccine is working properly and to check for unwanted effects.


Make sure your child's doctor knows if your child is receiving medicine or a procedure that may weaken the immune system, such as steroids, cancer medicines, or radiation. Tell your child's doctor if your child spends time with a person who has an immune system problem or is getting cancer medicines.


The oral applicator of this vaccine contains dry natural latex rubber. Make sure your child's doctor knows if your child has had an allergic reaction to latex rubber.


Call your child's doctor right away if your child has diarrhea, blood in the stool, a high fever, severe stomach pain, or vomiting. These could be symptoms of a serious bowel problem called intussusception.


Rotarix Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Diarrhea

  • fever

  • nausea and vomiting

  • pain or cramping in the abdomen or stomach

Rare
  • Confusion

  • decreased urination

  • dizziness

  • dry mouth

  • fainting

  • increase in heart rate

  • lightheadedness

  • loss of appetite

  • rapid breathing

  • sunken eyes

  • thirst

  • unusual tiredness or weakness

  • wrinkled skin

Incidence not known
  • Black, tarry stools

  • blood in the urine

  • bloody nose

  • heavier menstrual periods

  • pinpoint red spots on the skin

  • red eyes

  • red mouth

  • skin rash

  • swollen glands

  • swollen hands and feet

  • unusual bleeding or bruising

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Cough

  • crying, fussiness, or irritability

  • runny nose

Less common
  • Bloated

  • excess air or gas in the stomach or intestines

  • full feeling

  • passing gas

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Rotarix side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Rotarix resources


  • Rotarix Side Effects (in more detail)
  • Rotarix Use in Pregnancy & Breastfeeding
  • Rotarix Drug Interactions
  • Rotarix Support Group
  • 0 Reviews for Rotarix - Add your own review/rating


  • Rotarix MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rotarix Prescribing Information (FDA)

  • Rotarix Consumer Overview

  • RotaTeq MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rotateq Prescribing Information (FDA)

  • Rotateq Consumer Overview

  • Rotavirus Vaccine Live Oral Monograph (AHFS DI)



Compare Rotarix with other medications


  • Gastroenteritis